Stereotaxis, Inc. provided revenue guidance for the year 2022. The company anticipates revenue growth for the year, driven by continued commercial adoption of the Genesis RMN system and stable recurring revenue. Based on current customer schedules, the majority of system revenue for the year will be recognized in the second half of the year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.02 USD | -3.35% | -3.35% | +15.43% |
05-13 | Transcript : Stereotaxis, Inc., Q1 2024 Earnings Call, May 13, 2024 | |
05-13 | Stereotaxis to Buy Access Point Technologies | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.43% | 166M | |
+10.22% | 223B | |
+12.99% | 194B | |
+18.09% | 141B | |
+28.66% | 109B | |
+1.67% | 64.85B | |
+14.70% | 52.7B | |
+6.68% | 51.77B | |
+8.29% | 44.12B | |
+2.60% | 36.21B |
- Stock Market
- Equities
- STXS Stock
- News Stereotaxis, Inc.
- Stereotaxis, Inc. Provides Revenue Guidance for the Year 2022